Scientists at Michigan Medicine have made a significant breakthrough in treating nonalcoholic fatty liver disease (NAFLD), a ...

Since symptoms don’t appear until the condition worsens, the only way to detect fatty liver early is through blood tests (LFT ...

One of these is non-alcoholic steatohepatitis, or NASH, the fatty liver disease that affects millions of people and which is poised to be one of pharma’s next big growth areas. Novartis ramped ...

Elevated fat levels in your liver can raise your chances of developing serious health issues, including diabetes, ...

Nonalcoholic fatty liver disease (NAFLD) and its progressive form, nonalcoholic steatohepatitis (NASH) are the most common causes of chronic liver disease in industrialized countries. NAFLD has ...

It is the progressive form of non-alcoholic fatty liver disease (NAFLD). NASH can lead to cirrhosis and liver cancer. In individuals with obesity and compensated metabolic dysfunction-associated ...

Nonalcoholic fatty liver disease (NAFLD ... Nonalcoholic steatohepatitis (NASH) is the progressive form of liver injury that carries a risk for progressive fibrosis, cirrhosis, and end-stage ...

A study from Massachusetts General Hospital has found that growth hormone may help improve liver health in people with ...

In the medical field, terminology not only guides clinical understanding and patient communication but also impacts research, ...

Watch what you eat. Fatty buildup in your liver can cause nonalcoholic steatohepatitis and lead to cirrhosis. NASH is linked to high cholesterol, coronary artery disease, obesity, and diabetes.

Non-alcoholic fatty liver disease (NAFLD) affects nearly 19 crore people in India and about a quarter of the world’s ...